Search Results - "Kulp SK"

PPARgamma-independent antitumor effects of thiazolidinediones.

Authors: Wei S Yang J Lee SL et al.

Source: Cancer Letters. Apr2009, Vol. 276 Issue 2, p119-124. 6p.

Fc gamma receptor binding modulates IgG clearance in cancer cachexia.

Authors: Remaily BC Kim K Thomas J et al.

Source: Frontiers in immunology [Front Immunol] 2026 Mar 31; Vol. 17, pp. 1676732. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance.

Authors: Remaily BC Young G Lathrop H et al.

Source: Frontiers in immunology [Front Immunol] 2025 Dec 17; Vol. 16, pp. 1669979. Date of Electronic Publication: 2025 Dec 17 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Natural Product Target Identification of Wheldone, a Fungal Metabolite, as a KIF11 Inhibitor in Ovarian Cancer Using the DiffPOP (Differential Protein Precipitation) Method.

Authors: Khin M Saldana AC Rangel-Grimaldo M et al.

Source: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2026 May; Vol. 25 (5), pp. 101558. Date of Electronic Publication: 2026 Mar 23.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexia.

Authors: Adeluola A Thomas J Remaily B et al.

Source: International immunopharmacology [Int Immunopharmacol] 2026 Aug 01; Vol. 182, pp. 116788. Date of Electronic Publication: 2026 May 07.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia.

Authors: Das A Mukherjee D D'Alesio L et al.

Source: Cancers [Cancers (Basel)] 2026 Feb 11; Vol. 18 (4). Date of Electronic Publication: 2026 Feb 11.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonist.

Authors: Young GM Helms TH Kulp SK et al.

Source: Scientific reports [Sci Rep] 2025 Nov 03; Vol. 15 (1), pp. 38377. Date of Electronic Publication: 2025 Nov 03.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma.

Authors: Hoelzen EJ Radomska HS Kulp SK et al.

Source: Cancers [Cancers (Basel)] 2025 Jul 31; Vol. 17 (15). Date of Electronic Publication: 2025 Jul 31.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.

Authors: Taheri H Li Y Huang KM et al.

Source: Cancer research communications [Cancer Res Commun] 2025 Mar 01; Vol. 5 (3), pp. 496-510.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice.

Authors: Remaily BC Vu TT Thomas J et al.

Source: JCSM communications [JCSM Commun] 2025 Jan-Jun; Vol. 8 (1). Date of Electronic Publication: 2025 Feb 06.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Periodicals LLC Country of Publication: United States NLM ID: 9918994794906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2996-1394 (Electronic) Linking ISSN: 29961394 NLM ISO Abbreviation: JCSM Commun Subsets: PubMed not MEDLINE

The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists.

Authors: Adeluola AA Radomska HS Wilson TA et al.

Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2025 Jan; Vol. 392 (1), pp. 100001. Date of Electronic Publication: 2024 Nov 22.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.

Authors: Guo Y Wei L Patel SH et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2022 Jun; Vol. 23 (4), pp. 345-355. Date of Electronic Publication: 2022 Jan 08.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.

Authors: Castillo AMM Vu TT Liva SG et al.

Source: JCSM rapid communications [JCSM Rapid Commun] 2021 Jul-Dec; Vol. 4 (2), pp. 232-244. Date of Electronic Publication: 2021 Feb 09.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101726459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2617-1619 (Electronic) Linking ISSN: 26171619 NLM ISO Abbreviation: JCSM Rapid Commun Subsets: PubMed not MEDLINE

Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors.

Authors: Guo Y Remaily BC Thomas J et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 01; Vol. 30 (5), pp. 942-958.

Publication Type: Review; Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.

Authors: Vu TT Kim K Manna M et al.

Source: Pharmacological research [Pharmacol Res] 2024 Jan; Vol. 199, pp. 107048. Date of Electronic Publication: 2023 Dec 23.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE

Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats.

Authors: Xie Z Chen M Goswami S et al.

Source: The AAPS journal [AAPS J] 2020 Jul 16; Vol. 22 (4), pp. 92. Date of Electronic Publication: 2020 Jul 16.

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor.

Authors: Liva SG Tseng YC Dauki AM et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2020 Feb 07; Vol. 12 (2), pp. e9910. Date of Electronic Publication: 2020 Jan 13.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models.

Authors: Kaweesa EN Bazioli JM Pierre HC et al.

Source: Molecular pharmaceutics [Mol Pharm] 2023 Jun 05; Vol. 20 (6), pp. 3049-3059. Date of Electronic Publication: 2023 May 08.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE

Retraction: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.

Authors: Chu PC Kulp SK Chen CS

Source: Carcinogenesis [Carcinogenesis] 2019 Apr 29; Vol. 40 (2), pp. e14.

Publication Type: Journal Article; Retraction Notice

Journal Info: Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: PubMed not MEDLINE

Retraction: Corrigendum: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.

Authors: Chu PC Kulp SK Chen CS

Source: Carcinogenesis [Carcinogenesis] 2019 Apr 29; Vol. 40 (2), pp. e15.

Publication Type: Journal Article; Retraction Notice

Journal Info: Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: PubMed not MEDLINE